glutathion et parkinson Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Glutathione Precursors and Beyond Parkinson's Disease Treatment | IV
Description
2022;86(Pt 3):180188
However, the study used only one behavioral test (Elevated Plus Maze)
p=0.0152)
Parkinsons disease Parkinsons disease (PD) is the second most common neurodegenerative disease and affects 1% of the population over 60 years of age
Expression of nrf2 promotes schwann cell-mediated sciatic nerve recovery in diabetic peripheral neuropathy
